Neon Therapeutics, Inc. (NTGN) [Rocket]

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	21.4	18.3	10.9	7.7
General and administrative	21.4	18.3	10.9	7.7
Research and development	59.7	60.4	37.2	19.7
EBITDA [+]	-79.5	-77.2	-47.2	-27.0
EBITDA growth	2.9%	63.8%	74.6%
Depreciation and amortization	1.6	1.5	0.9	0.4
EBIT [+]	-81.1	-78.7	-48.1	-27.4
EBIT growth	3.1%	63.7%	75.4%
Interest income	1.4	1.8	0.6
Interest income	1.4	1.8	0.6
Other income (expense), net [+]	0.0	0.0	0.0	0.0
Other non-ooperating expenses	0.0	0.0	0.0	0.0
Other	1.4	1.8	0.6	0.0
Pre-tax income	-79.8	-76.9	-47.5	-27.4
Income taxes	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%
Net income	-79.8	-83.3	-57.9	-30.4

Basic EPS [+]	($2.86)	($5.54)	($34.32)	($30.72)
Growth	-48.3%	-83.9%	11.7%
Diluted EPS [+]	($2.86)	($5.54)	($34.32)	($30.72)
Growth	-48.3%	-83.9%	11.7%

Shares outstanding (basic) [+]	27.9	15.0	1.7	1.0
Growth	85.4%	790.9%	70.5%
Shares outstanding (diluted) [+]	27.9	15.0	1.7	1.0
Growth	85.4%	790.9%	70.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.